Search research articles
Contact Us
Filters
Showing results (41-50 of 151) with videos related to
Page
of 16
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
September 22, 2009
Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis
Anastasia Constantinidou, Robin L Jones, Michelle Scurr, et al.
Clinical Sarcoma Research
|
November 29, 2016
UK guidelines for the management of soft tissue sarcomas
Adam Dangoor, Beatrice Seddon, Craig Gerrand, et al.
Pathology, Research and Practice
|
May 9, 2016
ALK-positive inflammatory myofibroblastic tumor harboring ALK gene rearrangement, occurring after allogeneic stem cell transplant in an adult male
Katherine Vroobel, Ian Judson, Melissa Dainton, et al.
Progress in Cell Cycle Research
|
November 5, 2003
The contemporary drug development process: advances and challenges in preclinical and clinical development
Michelle D Garrett, Mike I Walton, Edward McDonald, et al.
Clinical Sarcoma Research
|
May 4, 2017
UK clinical practice guidelines for the management of gastrointestinal stromal tumours (GIST)
Ian Judson, Ramesh Bulusu, Beatrice Seddon, et al.
Investigational New Drugs
|
October 8, 2005
Phase I study of vinflunine administered as a 10-minute infusion on days 1 and 8 every 3 weeks
Peter Johnson, Thomas Geldart, Pierre Fumoleau, et al.
Clinical Sarcoma Research
|
November 28, 2013
Pazopanib is an active treatment in desmoid tumour/aggressive fibromatosis
Juan Martin-Liberal, Charlotte Benson, Heather McCarty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2007
HDAC inhibitors and cardiac safety
Rhoda Molife, Peter Fong, Michelle Scurr, et al.
Anticancer Research
|
January 1, 2015
Systemic treatment options for epithelioid haemangioendothelioma: the Royal Marsden Hospital experience
Nadia Yousaf, Marco Maruzzo, Ian Judson, et al.
Langenbeck'S Archives of Surgery
|
January 14, 2014
Prognostic factors for primary gastrointestinal stromal tumours: are they the same in the multidisciplinary treatment era?
Ferdinando C M Cananzi, Bruno Lorenzi, Ajay Belgaumkar, et al.
Page
of 16
Search research articles
Search
Showing results (41-50 of 151) with videos related to
Sort By:
Page
of 16
European Journal of Cancer (Oxford, England : 1990)
|
September 22, 2009
Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis
Anastasia Constantinidou, Robin L Jones, Michelle Scurr, et al.
Clinical Sarcoma Research
|
November 29, 2016
UK guidelines for the management of soft tissue sarcomas
Adam Dangoor, Beatrice Seddon, Craig Gerrand, et al.
Pathology, Research and Practice
|
May 9, 2016
ALK-positive inflammatory myofibroblastic tumor harboring ALK gene rearrangement, occurring after allogeneic stem cell transplant in an adult male
Katherine Vroobel, Ian Judson, Melissa Dainton, et al.
Progress in Cell Cycle Research
|
November 5, 2003
The contemporary drug development process: advances and challenges in preclinical and clinical development
Michelle D Garrett, Mike I Walton, Edward McDonald, et al.
Clinical Sarcoma Research
|
May 4, 2017
UK clinical practice guidelines for the management of gastrointestinal stromal tumours (GIST)
Ian Judson, Ramesh Bulusu, Beatrice Seddon, et al.
Investigational New Drugs
|
October 8, 2005
Phase I study of vinflunine administered as a 10-minute infusion on days 1 and 8 every 3 weeks
Peter Johnson, Thomas Geldart, Pierre Fumoleau, et al.
Clinical Sarcoma Research
|
November 28, 2013
Pazopanib is an active treatment in desmoid tumour/aggressive fibromatosis
Juan Martin-Liberal, Charlotte Benson, Heather McCarty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2007
HDAC inhibitors and cardiac safety
Rhoda Molife, Peter Fong, Michelle Scurr, et al.
Anticancer Research
|
January 1, 2015
Systemic treatment options for epithelioid haemangioendothelioma: the Royal Marsden Hospital experience
Nadia Yousaf, Marco Maruzzo, Ian Judson, et al.
Langenbeck'S Archives of Surgery
|
January 14, 2014
Prognostic factors for primary gastrointestinal stromal tumours: are they the same in the multidisciplinary treatment era?
Ferdinando C M Cananzi, Bruno Lorenzi, Ajay Belgaumkar, et al.
Page
of 16